Prevalence of Unknown and Known Diabetes in Patients With Frozen Shoulder
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01978886|
Recruitment Status : Completed
First Posted : November 8, 2013
Last Update Posted : February 11, 2016
The purpose of the study is to investigate how high the prevalence of diabetes (known and unknown) is among patients with a frozen shoulder. Our hypothesis is that it is around 30-40 %.
Another purpose is to investigate whether patients with diabetes have a worse and more painful frozen shoulder than patients without diabetes, and whether the diabetes have an influence on the prognosis.
|Condition or disease|
|Diabetes Mellitus Frozen Shoulder|
Patients who are not diagnosed with diabetes would be ask to give a blood sample to investigate if they have an unknown diabetes.
All patients with frozen shoulder will be asked to fill out a questionnaire (Oxford Shoulder Score) to clarify how bad their frozen shoulder is. All patients will receive the questionnaire 6 and 24 month following the date on inclusion.
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||220 participants|
|Target Follow-Up Duration:||2 Years|
|Official Title:||Prevalence of Unknown and Known Diabetes in Patients With Frozen Shoulder|
|Study Start Date :||December 2013|
|Actual Primary Completion Date :||February 2016|
|Actual Study Completion Date :||February 2016|
Patient with diabetes
Patients who have been diagnoses with diabetes.
Patients without diabetes
Patients who have not previous been diagnosed with diabetes.
- prevalence of known and unknown diabetes diabetes [ Time Frame: 1 year ]
- diabetes influence on the prognosis of frozen shoulder [ Time Frame: 24 months ]how the status of diabetes influence the prognosis of frozen shoulder. The patient will be asked to fill out oxford shoulder score at the time of inclusion and at 6 and 24 months follow-up. The two groups (patients with and without diabetes) will be compared using the oxford shoulder score.
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01978886
|Amager, Copenhagen, Denmark, 2300|
|Kolding, Denmark, 6000|
|Vejle, Denmark, 7100|
|Principal Investigator:||per h gundtoft, md||Sygehus Lillebaelt|